Investment
Features
FeesSafety
Academy
More
Pluang+

AI and DeFi tokens lead new asset launches on Huobi HTX, with one asset nearly doubling in value.

Market News
13 Jul 2026
Coincu
View Source
Bullish
pluang ai news

Between July 6 and 12, Huobi HTX launched several new assets, with tokens related to artificial intelligence (AI) and decentralized finance (DeFi) showing the strongest performance. One standout asset nearly doubled in price during its initial trading days, reflecting high early demand. This trend highlights trader preference for tokens with clear sector narratives, although such early gains may not predict long-term performance. Future weekly reviews will reveal if AI and DeFi continue to dominate new listings on the platform.

More News

Noble Capital Markets starts coverage on VivoPower with Outperform rating and $10 target

Noble Capital Markets starts coverage on VivoPower with Outperform rating and $10 target

Noble Capital Markets has initiated equity research coverage on VivoPower PLC, assigning an Outperform rating and setting a price target of $10. VivoPower is a B Corp-certified global developer of powered land and data center infrastructure for AI ap...

Analyst Insights
Bullish
36 minutes ago
Head and neck squamous cell carcinoma market to grow 10.5% CAGR through 2036 with new immunotherapies.

Head and neck squamous cell carcinoma market to grow 10.5% CAGR through 2036 with new immunotherapies.

The head and neck squamous cell carcinoma (HNSCC) market is projected to grow at a 10.5% CAGR from 2026 to 2036, driven by rising cancer incidence and new immunotherapy launches. Key emerging therapies from companies like Johnson & Johnson, BioNTech,...

Market News
Bullish
36 minutes ago
Alamar Biosciences launches national study analyzing 21,000 plasma samples to advance Alzheimer's biomarkers.

Alamar Biosciences launches national study analyzing 21,000 plasma samples to advance Alzheimer's biomarkers.

Alamar Biosciences has partnered with top U.S. research universities to start a nationwide proteomics project using its NULISAseq™ Neuro 220 panel. The study will analyze about 21,000 plasma samples from 10,000 Alzheimer's and related dementia partic...

Market News
Bullish
45 minutes ago
Alamar Biosciences launches national study using blood tests to advance Alzheimer's biomarker research.

Alamar Biosciences launches national study using blood tests to advance Alzheimer's biomarker research.

Alamar Biosciences has partnered with leading U.S. universities to launch a nationwide proteomics study analyzing around 21,000 plasma samples from 10,000 Alzheimer's and related dementia patients. Using its NULISAseq™ Neuro 220 test kit, the project...

Market News
Bullish
45 minutes ago
VINCI repurchases 400,000 shares between July 6-10, 2026, at an average price of €121 each.

VINCI repurchases 400,000 shares between July 6-10, 2026, at an average price of €121 each.

VINCI SA announced it repurchased a total of 400,000 treasury shares from July 6 to July 10, 2026, under authorization from its April 2026 General Meeting. The shares were bought at an average weighted price of approximately €120.99 per share across ...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App